[Trp3,Arg5]-Ghrelin (1-5) CAS NO. 848442-59-1

[Trp3,Arg5]-Ghrelin (1-5) CAS NO. 848442-59-1

[Trp3,Arg5]-Ghrelin (1-5)  CAS NO. 848442-59-1

[Trp3,Arg5]-Ghrelin (1-5) CAS NO. 848442-59-1

[Trp3,Arg5]-Ghrelin (1-5) CAS NO. 848442-59-1

[Trp3,Arg5]-Ghrelin (1-5) is a synthetic pentapeptide analog derived from the N-terminal bioactive core of ghrelin, featuring specific amino acid substitutions at positions 3 and 5. This analog has the sequence H-Gly-Ser-Trp-Arg-Leu-OH (with tryptophan at position 3 and arginine at position 5). Designed to mimic the minimal active region of ghrelin necessary for Growth Hormone Secretagogue Receptor 1a (GHSR1a) binding, this modified analog is typically used to study structure-activity relationships, receptor binding, and truncated ghrelin functions. 

TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
[Trp3,Arg5]-Ghrelin (1-5)
CAS NO.
848442-59-1
Appearance
White to off-white lyophilized powder
Molecular Formula
C31H41N9O7
Molecular Weight
651.73g/mol 
Purity (RP-HPLC)
≥98.0% 
Solubility

Soluble in water (≥10 mg/mL), dilute acetic acid, and DMSO

Endotoxin< 1.0 EU/mg
Biological Activity
 A modified ghrelin fragment that acts as a selective agonist for the ghrelin receptor (GHSR-1a), with potent appetite-stimulating effects.
Storage Conditions
Store at -20°C to -80°C in a sealed container, protected from moisture and light. Stable for 1 year at -20°C, 2 years at -80°C. Avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

This analog functions primarily as a Growth Hormone Secretagogue Receptor 1a (GHSR1a) agonist or partial agonist. The N-terminal 1-5 sequence of ghrelin is known to be the minimal fragment retaining binding affinity to GHSR1a, a G-protein coupled receptor. The [Trp3,Arg5] substitutions are designed to enhance receptor interaction, stability, or selectivity. Upon binding, it activates the Gq/11 signaling pathway, leading to phospholipase C (PLC) activation, inositol trisphosphate (IP3) production, diacylglycerol (DAG) release, intracellular calcium mobilization, and ultimately growth hormone (GH) release from the pituitary. 


    2.PRODUCT INDICATIONS

  • Structure-Activity Relationship (SAR) Studies: Investigating the impact of specific amino acid substitutions (Trp3, Arg5) on receptor binding affinity, selectivity, and functional activity at GHSR1a.

  • Minimal Active Sequence Research: Defining the shortest peptide sequence required for GHSR1a activation and studying the bioactivity of ghrelin fragments.

  • In VitroReceptor Pharmacology: Serving as a reference ligand or tool compound in GHSR1a binding assays (competitive displacement) and functional assays (e.g., calcium flux, inositol phosphate accumulation).

  • Drug Discovery: Used as a scaffold or lead compound in the design and development of novel GHSR1a agonists, antagonists, or allosteric modulators with improved pharmacokinetic properties.

  • Physiological Studies: Exploring the potential biological roles of truncated ghrelin peptides in growth hormone regulation, appetite, and metabolism in preclinical models.


    3.CLINICAL EFFICACY OF PRODUCT

  • Research Utility: Its value lies in basic science and drug discovery. Studies using this analog help elucidate how specific amino acids in ghrelin contribute to receptor binding and activation, guiding the rational design of future therapeutics.

  • Therapeutic Target Validation: Research with such analogs validates GHSR1a as a target for conditions like growth hormone deficiency, cachexia, or obesity.

  • Clinical Translation Gap: This specific peptide is not a drug candidate itself. Any clinical application would stem from the development of optimized, stable, and safe GHSR1a modulators (agonists or antagonists) whose design may be informed by studies with fragments like this one.

  • Status: No clinical trials have been conducted with [Trp3,Arg5]-Ghrelin (1-5). Its efficacy is measured in terms of in vitroreceptor potency and in vivoactivity in animal models, not in human patients.


  • 4.DELIVERY & SHIPPING

    We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
    Professional and Secure Packaging
    Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
    We can also customize packaging according to customer needs.
    Shipping Methods 
    Main Method: International Air Freight

    We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.